Select for export Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/head.14420 PubMed 36416492 Copy citation Copy BibTeX Headache The Journal of Head and Face Pain 2022-11-22 Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y Europe PMC Published psilocybin Headache / MigraineAdverse Events Clinical Trial More
Select for export Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cbic.202200551 PubMed 36327140 Copy citation Copy BibTeX ChemBioChem 2022-11-21 Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D. Europe PMC Published psilocybin DepressionIn Vitro Study In Vitro Study More
Select for export Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ijms232214148 PubMed 36430623 Copy citation Copy BibTeX International Journal of Molecular Sciences 2022-11-15 Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A Europe PMC Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.11.15.516655 Copy citation Copy BibTeX bioRxiv 2022-11-14 Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. bioRxiv PREPRINT (not peer reviewed) psilocin NeuroplasticityMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Body mass index (BMI) does not predict responses to psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131994 PubMed 36373934 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-13 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T Europe PMC Published psilocybin Receptor PharmacologyWellbeingEmotional Processing Other More
Select for export Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s13205-022-03355-4 PubMed 36340802 Copy citation Copy BibTeX Unknown journal 2022-11-03 Strauss D, Ghosh S, Murray Z, Gryzenhout M. Europe PMC Published psilocybinpsilocin Receptor PharmacologyReview Article Review Article More
Select for export The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11064-022-03772-0 PubMed 36327017 Copy citation Copy BibTeX Unknown journal 2022-11-02 VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Review Article More
Select for export Psilocybin reduces symptoms in treatment resistant depression, trial results show. No abstract availability was recorded for this entry. Details DOI 10.1136/bmj.o2623 PubMed 36411539 Copy citation Copy BibTeX BMJ 2022-11-01 Iacobucci G. Europe PMC Published psilocybin Depression Other More
Select for export Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cct.2022.106976 PubMed 36332827 Copy citation Copy BibTeX Contemporary Clinical Trials 2022-11-01 O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J Europe PMC Published psilocybin AddictionReceptor PharmacologyRandomized Controlled Trial Randomized Controlled Trial More
Select for export Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/adb.13229 PubMed 36301215 Copy citation Copy BibTeX Unknown journal 2022-10-31 Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Systematic Review More
Select for export Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer. No abstract availability was recorded for this entry. Details DOI 10.46747/cfp.6811823 PubMed 36376043 Copy citation Copy BibTeX Canadian Family Physician 2022-10-31 Patchett-Marble R, O'Sullivan S, Tadwalkar S, Hapke E. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export [Treatment-resistant depression. From classification to new therapies.] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1708/3922.39072 PubMed 36503940 Copy citation Copy BibTeX Rivista di psichiatria 2022-10-31 Paganin W, Signorini S, Leccese V, Sciarretta A. Europe PMC Published psilocybin DepressionAgingTreatment-Resistant Depression Other More
Select for export Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1056/nejmoa2206443 PubMed 36322843 Copy citation Copy BibTeX New England Journal of Medicine 2022-10-31 Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin in Treatment-Resistant Depression. No abstract availability was recorded for this entry. Details DOI 10.1056/nejme2210975 PubMed 36322849 Copy citation Copy BibTeX Unknown journal 2022-10-31 Madras BK. Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Microdosing with classical psychedelics: Research trajectories and practical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/13634615221129115 PubMed 36317302 Copy citation Copy BibTeX Unknown journal 2022-10-30 Wong A, Raz A. Europe PMC Published psilocybin ConsciousnessMicrodosingCreativity Other More
Select for export Five new species of Inosperma from China: Morphological characteristics, phylogenetic analyses, and toxin detection. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fmicb.2022.1021583 PubMed 36386664 Copy citation Copy BibTeX Frontiers in Microbiology 2022-10-30 Li SN, Xu F, Long P, Liu F, Zhang P, Fan YG Europe PMC Published psilocybin General Other More
Select for export Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221127304 PubMed 36314881 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-10-30 Jones GM. Europe PMC Published psilocybin DepressionObservational StudyDrug Interactions Observational Study More
Select for export Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2022.119716 PubMed 36341951 Copy citation Copy BibTeX NeuroImage 2022-10-26 Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S Europe PMC Published psilocybinpsilocin Brain ImagingConsciousnessAging Other More
Select for export Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/13634615221131465 PubMed 36263513 Copy citation Copy BibTeX Unknown journal 2022-10-18 Dupuis D, Veissière S. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression. No abstract availability was recorded for this entry. Details DOI 10.1097/jcp.0000000000001610 PubMed 36251379 Copy citation Copy BibTeX Unknown journal 2022-10-15 Balon R. Europe PMC Published psilocybin Depression Other More
